|Bid||5.84 x 4000|
|Ask||5.85 x 800|
|Day's Range||5.62 - 6.06|
|52 Week Range||4.05 - 12.52|
|Beta (3Y Monthly)||2.34|
|PE Ratio (TTM)||28.06|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Yahoo Finance's Julie Hyman highlights todays stocks on the move in midday trading.
Investorideas.com, a leading investor news resource for cannabis stocks releases a snapshot looking at CBD and its future role as a pain treatment in healthcare, and how it is being advocated and embraced by professional athletes. The World Anti-Doping Agency (WADA) officially removed cannabidiol (CBD) from its Prohibited Substances List effective January 1, 2018 and that has opened up a lot of opportunity for athletes looking for more natural pain treatment solutions and companies in the space. In June of this year, The BIG3 basketball league announced they will allow players to use cannabidiol (CBD) as a pain treatment and for recovery.
A major shift in healthcare could rival this new industry as the biggest health insurer in the U.S., Medicare & Medicaid, tries to save money by moving more procedures (and patients) out of hospitals into smaller surgical centers and get them out of the surgical setting rapidly. Medicare is already saving billions each year according to a recent study and is hoping to save almost $60 billion in the coming years through this huge cost cutting measure. Remote patient monitoring, already a big and lucrative business, is likely to become a whole lot larger.
Two sectors we see a lot of value in right now are oil and gas exploration as well as cannabis stocks HENDERSON, NV / ACCESSWIRE / November 19, 2018 / Today we are highlighting: Camber Energy, Inc. (CEI), ...
POINT ROBERTS, Wash. and LAS VEGAS, Nov. 19, 2018 (GLOBE NEWSWIRE) -- www.Investorideas.com, a global news source covering marijuana and hemp stocks and its cannabis podcast site www.potcasts.ca report from Las Vegas at this year’s biggest MJBizCon show to date, from the first ever Podcasters Row. Since it was founded seven years ago, MJBizCon has grown to become the largest trade show in the cannabis industry. This year’s record attendance was a notable reflection of the sectors growth and all the industry professionals on the floor were impressed.
After a week of earnings reports from some of the largest cannabis producers in Canada and a month of legal marijuana, a clear picture has emerged: the shortages the country experienced on the first day of recreational legalization occurred, in large part, because the heavyweights didn’t ship very much pot.
NEW YORK, NY / ACCESSWIRE / November 19, 2018 / U.S. equities finished mostly in the green on Friday as investors digested comments from President Donald Trump, expressing confidence in resolving the current ...
HENDERSON, NV / ACCESSWIRE / November 16, 2018 / In October, Canada became the first industrialized country in the world to legalize recreational marijuana. Wall Street is calling for upwards of $5 billion ...
NEW YORK, Nov. 16, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
The global legal marijuana market is expected to reach USD 146.4 billion by end of 2025, according to a new report by Grand View Research, Inc. Growing adoption of marijuana in several medical applications such as cancer, mental disorders, chronic pain, and others is expected to propel revenue growth in the near future. As the industry continues to gain the attention of early investors, companies like Premier Health Group, Inc. (PHGRF) (PHGI), Aurora Cannabis (ACB)(ACB), New Age Beverages (NBEV), and Tilray (TLRY) are working toward new sector growth. Premier Health Group, Inc. (PHGRF) (PHGI) is focused on developing innovative approaches that combine human skill-based expertise with emerging technologies for the healthcare industry.
Aurora Cannabis Inc (NYSE: ACB) made an addition to its executive team with new chief science officer. Aurora appointed Dr. Jonathan Page as the new Chief Science Officer. Page received his PhD at the University of British Columbia and is currently an adjunct professor in the Botany Department at the university.
For marijuana investors Aurora Cannabis (NYSE:ACB) has a lot going for it. Aurora stock has that New York Stock Exchange listing, which was launched on Oct, 23. Pot stocks were always a fad, like bitcoin last year, and with people worried more about keeping their money than getting more, pot stocks are being roundly dropped. Canada began legal pot sales in October, with plans to expand that into edibles and vaping.
The United States and Canada have moved in different ways toward the legalization of marijuana in certain circumstances for years. Now, more than 20 states have legalized cannabis for medical or recreational purposes (or both), and Canada moved to legalize recreational cannabis use for adults in October of this year. Unsurprisingly, companies in the legal marijuana space and investors alike have been clamoring to take part in what many believe is a promising and fast-growing new industry.
Promotes Dr. Shane Morris to SVP Product Development and Regulatory Affairs TSX/NYSE: ACB EDMONTON , Nov. 14, 2018 /PRNewswire/ - Aurora Cannabis Inc. (TSX: ACB) (NYSE: ACB) ( Frankfurt : 21P; WKN: A1C4WM) ...
There’s no need to mince words: Tilray (NASDAQ:TLRY) stock isn’t responding all that well to last quarter’s results. Tilray stock fell to the tune of 10% on Wednesday despite reporting third-quarter earnings estimates that were better-than-expected after Tuesday’s closing bell rang. Granted, revenue came up short of expectations, and despite the improved bottom line, the (legalized) marijuana provider still booked a loss.
HENDERSON, NV / ACCESSWIRE / November 14, 2018 / The current market correction has hit every sector including cannabis. Despite impressive news across many of the sector’s leaders, stocks are down across ...
When the market is volatile, investors flee to safety. Often, investors will retreat out of growth names and into more established industries. We saw that trend play out in October on the over-the-counter ...
Tilray (TLRY) reported solid revenue but a decline in average selling prices in the third quarter as the Canadian cannabis producer works to address a growing medical and adult-use market. Although Tilray more than doubled the amount of cannabis sold in the third quarter of 2018 over last year, average selling prices fell by $1.32 per gram, putting pressure on margins. Gross margins were about 30% in the third-quarter versus 55% in the same period last year.
Yahoo Finance's LIVE market coverage and analysis of what you need to watch in the stock market begins each day at 9:00 a.m. ET.
NEW YORK, NY / ACCESSWIRE / November 14, 2018 / Cronos Group shares were in the red despite announcing a revenue jump in the third quarter yesterday. Shares of Aurora Cannabis were also in the red after reporting earlier in the week that earnings grew by 2,800% in the first quarter. Cronos Group Inc. shares were down 1.66% on Tuesday on a little under 8.5 million shares traded.
The company reported a 213% increase in the cannabis it sold to 514 kilograms thanks to an increase in production capacity and increased volumes sold through Canadian medical and international channels.
HENDERSON, NV / ACCESSWIRE / November 13, 2018 / Last Tuesday's election was great news for cannabis companies. With Michigan approving recreational marijuana and several other measures passing investors ...
Cronos Group Inc (NASDAQ: CRON)'s stock opened lower Tuesday after the company reported third-quarter results. Cronos Group reported revenue of $3.8 million for the quarter, up 186 percent on the year and substantially higher than the consensus estimate of $2.72 million.